JavaScript is off. Please enable to view full site.

Novartis honored at National Health Digital Transformation Congress

Novartis honored at National Health Digital Transformation Congress

Thursday, February 18, 2021, 19:00 GMT+7
Novartis honored at National Health Digital Transformation Congress
The National Health Digital Transformation Congress in Hanoi on December 29 and 30, 2020

At the National Health Digital Transformation Congress 2020, Novartis Vietnam (Novartis) was honored as one of 34 units that have made a positive contribution to the digital transformation of the health sector in the country.

Thanks to a long-term strategic vision, Novartis has been early aware of the significance of digital transformation in healthcare.

The year 2020 also marked many remarkable achievements of the pharmaceutical company.

Particularly, Novartis has pioneered the application of the Docquity platform to organizing activities and programs to provide updated knowledge for Vietnamese medical staff.

It is known that Docquity is an online community dedicated to health workers in Asia.

Moreover, Novartis has successfully partnered with health organizations and Hello Doctors to support public health awareness while cooperating with Samsung SDS in applying Brightics RA artificial intelligence technology to routine eye disease screening.

Notably, Novartis has partnered and sponsored healthcare organizations to successfully implement the program of Tam Diem.

This is a series of webinars held weekly to provide the latest scientific information for cardiologists.

Moreover, at the end of 2020, Novartis also officially launched MedHub – an online medical portal for health staff which is considered a significant milestone in the company's digital road map to improve customer experience.

Novartis, a pharmaceutical company, was honored in the digital transformation of the health sector.

Novartis, a pharmaceutical company, was honored in the digital transformation of the health sector.

“We are very delighted and highly appreciate the recognition from the Vietnamese government, the Ministry of Health, and other authorities for Novartis’ continuous contributions toward the digitalization journey of Vietnam’s healthcare,” said Amitabh Dube, country president at Novartis Vietnam.

“We look forward to building the long-term, sustainable partnership and going hand in hand with Vietnam’s government in helping patients get more convenient, faster, and quality access to healthcare services.”

In early 2020, Novartis Vietnam Ltd. successfully transformed into a foreign-invested enterprise and fully operationalized its import activities.

Through long-term commitments, Novartis is supporting Vietnam’s domestic healthcare system and contributing to the country’s socio-economic development.

Novartis is a leader in innovative medicines across many therapeutic areas, namely oncology, cardiology (hypertension, heart failure, diabetes), respiratory diseases (asthma, COPD), ophthalmology, pain relief, neuroscience, dermatology and immunology, cell and gene therapy, and others.

The company is a leader in high-quality generics and biosimilars through the firm’s Sandoz arm, and one of the largest investors in clinical trials in Vietnam.

Yen Viet

More

Read more

;

Photos

VIDEOS

‘Taste of Australia’ gala dinner held in Ho Chi Minh City after 2-year hiatus

Taste of Australia Gala Reception has returned to the Park Hyatt Hotel in Ho Chi Minh City's District 1 after a two-year hiatus due to the COVID-19 pandemic

Vietnamese woman gives unconditional love to hundreds of adopted children

Despite her own immense hardship, she has taken in and cared for hundreds of orphans over the past three decades.

Vietnam’s Mekong Delta celebrates spring with ‘hat boi’ performances

The art form is so popular that it attracts people from all ages in the Mekong Delta

Vietnamese youngster travels back in time with clay miniatures

Each work is a scene caught by Dung and kept in his memories through his journeys across Vietnam

Latest news